Table 1.
Potential Therapeutic Approaches Currently Being Investigated
Mode of action | Stage | References | |
---|---|---|---|
p38 MAPK inhibitor | Inhibition of p53 pathway and SASP | In vitro | [Davis et al., 2005; Davis et al., 2016; Tivey et al., 2013] |
mTOR inhibitor | Stimulation of autophagy | In vitro | [Saha et al., 2014; Talaei et al., 2013] |
Vitamin C | Reduction of ROS | In vitro | [Aumailley et al., 2015a; Kashino et al., 2003; Li et al., 2016] |
Astaxanthin | Reduction of ROS | In vivo | [Takemoto et al., 2015] |
PTC read-through | Bypassing nonsense mutation | In vitro | [Agrelo et al., 2015] |
Stem cell gene therapy | Gene editing of stem cells | In vivo | [Cheung et al., 2014; Shimamoto et al., 2014; Shimamoto et al., 2015; Zhang et al., 2015] |